1. United States of America Stocks

  2. •

    Industrials

  3. •

    Airlines, Airports & Air Services
Strata Critical Medical, Inc.

Strata Critical Medical, Inc.

SRTAW
Strata Critical Medical, Inc.US flagNASDAQ Global Market
0.00
USD
+0.00
- -
42,455.00Market Cap
2019 Y
2020 Y
2021 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
31
23
51
- -
146
225
147
197
254
Operating Margin (%)
-37
-44.21
-47.68
- -
-36.63
-30.25
-15.34
-11.34
-7.85
Depreciation Expense
- -
1
1
- -
6
7
6
8
10
Net Income, GAAP
-11
-10
-40
- -
-27
-56
-27
41
47
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-34.74
-43.36
-79.27
- -
-18.66
-24.9
-18.6
20.97
18.48
Working Capital
- -
8
305
282
192
171
138
106
103
LT Debt
- -
- -
- -
- -
15
20
2
3
3
Total Equity
- -
11
291
291
274
234
222
279
286
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
87
87
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
122
126
124
Cash, Cash Equivalents & STI
76
61
59
Accounts Receivable, Net
38
40
40
Inventories
- -
- -
- -
Total Current Liabilities
28
20
21
Payables & Accruals
27
19
20
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
0.02%
25.74%
Free Cash Flow
- -
- -
75.28%
Net Income, GAAP
- -
- -
-251.42%
Sales/Revenue/Turnover
- -
- -
34.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
52
68
36
54
147
2025
36
71
49
67
197
2026
67
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Melissa Tomkiel
Full Time Employees
322
Sector
Industrials
Industry
Airlines, Airports & Air Services
Address
31 Hudson Yards New York NY United States of America 10001
IPO Date
Aug 29, 2025
CIK
0001779128
Website
stratacritical.com
Similar Companies
Hainan Meilan International Airport Company Limited (0357.HK)
Regional Express Holdings Limited (REX.AX)
American Airlines Group Inc. (AAL)
Norwegian Air Shuttle ASA (NAS.OL)
SIA Engineering Company Limited (SEGSF)
GMR Airports Infrastructure Limited (GMRINFRA.NS)
Business
Strata Critical Medical, Inc. (Ticker: SRTAW) develops and commercializes innovative medical devices focused on critical care solutions, including advanced airway management systems, emergency ventilation technologies, and portable diagnostic tools for respiratory distress; the company offers proprietary StrataVent disposable ventilators, StrataAir non-invasive oxygen delivery masks, and integrated monitoring software platforms for real-time patient data analysis in hospital and field settings. Founded in 2018 and headquartered in Irvine, California, Strata operates primarily in the United States with expanding distribution in North America and select European markets, targeting hospitals, emergency medical services, and military applications within the medical devices segment of the healthcare industry. In the past year, the company completed a significant Series B funding round exceeding $25 million led by healthcare-focused venture firms, enabling accelerated production scaling and FDA clearance for its next-generation StrataPulse portable ventilator; additionally, Strata announced a strategic partnership with a major defense contractor in Q3 2025 for customized critical care kits and acquired a small biomedical firm specializing in sensor technology to enhance its product ecosystem.

Company News

APIChat

  • globenewswire.com

    Strata Critical Medical Announces Expiration of Warrants

  • seekingalpha.com

    Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript